Received Apr 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 4L454 | — |
Patient was supposed to receive Pediarix but instead he received Kinrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 4-month-old male patient who received DTPa-IPV (Kinrix) (batch number 4L454, expiry date 16-OCT-2026) for prophylaxis. Co-suspect products included DTPa-HBV-IPV (Pediarix) for prophylaxis. On 23-APR-2025, the patient received the 1st dose of Kinrix. On an unknown date, the patient did not receive Pediarix. On 23-APR-2025, immediately after receiving Kinrix and not applicable after receiving Pediarix, the patient experienced wrong vaccine administered (Verbatim: Patient was supposed to receive Pediarix but instead he received Kinrix). The outcome of the wrong vaccine administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 23-APR-2025 The clinic had called because they had mistakenly administered the Kinrix vaccine to a four-month-old, even though it was indicated for children four years and older. As a result, they had a few questions regarding the situation. The patient was supposed to have received Pediarix, but instead, had been given Kinrix, which led to wrong vaccine administered. They had consented to a follow-up.